FDA Import Refusal 799-6175179-4/1/1 — Aventis Pharma Limited
The FDA refused shipment 799-6175179-4/1/1 from Aventis Pharma Limited (India) on Jul 1, 2016. The refused product falls under Drugs and Biologics — GLIBORNURIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jul 1, 2016
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCA07 GLIBORNURIDE (ANTI-DIABETIC)
- Charges
- 75